Global Epistaxis Market, By Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents)
Epistaxis is a commonly encountered clinical condition that results in uncertain nose bleeding from either of the nostrils. Epistaxis that is usually categorized as anterior and posterior epistaxis is rarely fatal and serious unless major disorders such as cancer or leukemia are associated with it. According to an article published by Life in the Fast Lane in 2011, nosebleeds commonly occur between the ages of 2-10 and 50-80 years, out of which the 50-80 contributes a major part. Thus, the increasing number of geriatric population is also responsible for boosting the growth of global epistaxis market. The same article states that emergency physicians report 90% success rate at treating acute epistaxis in the emergency department itself and the rest 10% is the cases requiring further management and assessment that can be categorized as critical cases. Epistaxis is known to be caused by local trauma that includes nasal or sinus infection and even extensive nose-picking. The environmental factors leading to epistaxis include dry and cold conditions, especially during winters or lack of humidity in the atmosphere that is usually encountered in the tropical regions. Several other factors causing epistaxis include platelet disorders, neoplasm, endometriosis, solvent inhalation, cocaine snorting, and consumption of anticoagulants.
Request For Sample Copy@
Recent studies have shown that epistaxis can be treated effectively even with simple medications. For instance, a case study published in the Journal of American Medical Association in September 2016, states that 121 patients with epistaxis sprayed either saline or standard medications for epistaxis such as estriol or tranexamic acid and surprisingly exhibited equal results leading to the discovery of a simple yet highly effective treatment for epistaxis emergency cases. Saline is easily available, as it is one of the basic goods sold at almost every pharmacy. This will, in turn, lead to enhancement of home care treatment and reduce doctor visits that will act as a point of benefit for the customers. According to the Heart Foundation, around 6 million people in Australia aged 18 years and above suffered from either systolic or diastolic blood pressure in 2015. The high blood pressure carries a dramatic risk for hypertension, which is the leading cause for epistaxis, mostly among the adult population. Thus, the demand for epistaxis treatment is expected to witness dramatic growth in the near future, creating lucrative opportunities for the market players to grab more sales with the introduction of cost-efficient and innovative devices.
Key Takeaways of the Epistaxis Market:
The global epistaxis market is expected to expand at a CAGR of 5.7% during the forecast period (2016–2025), as there exists a huge market potential, especially in Asia Pacific, Middle East, and Africa
Robust developments in cauterization procedures and rising number of patients suffering from hypertension are expected to drive the global epistaxis market
Blunt trauma, nose picking, overly sensitive blood vessels in the nasal septum, common colds and flu, hypersensitivity, foreign body invasion into the nasal cavity, nasal tumors, anti-inflammatory medicines, consumption of anticoagulants, and snorting of cocaine are a few of the most commonly observed causes leading to epistaxis
Some of the major players involved in the global epistaxis market include Smith & Nephew, Medline, Bristol-Myers Squibb Pharma Company, Ciron Drugs, and King Pharmaceutical, Inc.
Ask For the Discount@
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Epistaxis Market, By Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, Cauterizing Agents) here
News-ID: 768636 • Views: …
More Releases from Pharamceutical
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Congestive Heart Failure Drugs Market, by Drug Type ACE Inhibitors, Angiotensin …
Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these
New improved medication with lesser side effects will drive the insomnia therape …
Benzodiazepines (BZP) such as temazepam and diazepam are the commonly prescribed medication for insomnia. Though these medications are effective, prolonged use of these drugs may cause cognitive impairment, dependency and addiction. The launch of novel drugs such as Intermezzo (2014), tasimelteon (2014) have created a meteoric growth in G7 countries in the insomnia therapeutics and is expected market over the forecast period. Intermezzo (2014), are used in small doses and administered
Antiepileptic Drugs Market - Global Industry Insights,
Antiepileptic Drugs Market Regional Analysis North America and Europe are expected to witness significant growth in the market over the forecast period due to robust pipeline for epilepsy treatment and individual efforts by leading manufacturers. For instance, Pfizer, Inc. entered into partnership with Epilepsy Foundation to find solutions for generic forms of epilepsy and associated neurological disorders in 2014. Asia Pacific region is expected to show positive developments over the forecast
More Releases for Epistaxis
Epistaxis Market UpComing Developments With Major Key Players
The global epistaxis market was valued at US$ 130.0 million in 2016 and is expected to witness a CAGR of 5.7% during the forecast period (2017 – 2025). Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. According to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. According
Epistaxis Market to Witness an Outstanding Growth by 2026
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Market Research report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. Download Sample Copy of this report @ https://www.xploremr.com/connectus/sample/1819 Scope The scope of Market
Epistaxis Market Industry Forecast till 2025
Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season. Request Sample Copy of this Business Report
Epistaxis Market Projected to Discern Stable Expansion During 2026
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This Fact.MR report analyzes the expansion of global epistaxis market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. Report overview @ https://www.xploremr.com/report/1819/epistaxis-market Scope The scope of Fact.MR’s report is to analyze the
Epistaxis Market Report: Global Epistaxis Market Report Examines Latest Trends a …
Growing prevalence of hypertension is expected to impact the global epistaxis market. Instances of dry mucous membrane attributed to extreme weather conditions will continue to rev up demand for epistaxis products globally. This FactMR report analyzes the expansion of global Epistaxis Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026. The scope of FactMR’s report is to analyze the global epistaxis market
Epistaxis Market - Share, Growth, Trends and Forecast 2017 - 2025
Epistaxis is a condition that results in uncertain nose bleeding from either of the nostrils. This clinical condition is usually classified as anterior epistaxis and posterior epistaxis based on the site where the bleeding originates. Epistaxis is rarely life threatening unless it is associated with chronic disorders such as cancer. About 10% of nosebleeds is life threatening, and it is accounted that four of the 2.4 million deaths occur due